Trial intelligence / Profile preview

30/70 mixed recombinant human insulin vs Mixed Protamine Zinc Recombinant Human Insulin in type 2 diabetes

CTR20140675Phase 3Active

Sponsor
Zhejiang Hisun Pharmaceutical Co., Ltd.
Start
Oct 2014
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of biphasic human insulin in type 2 diabetes mellitus (T2DM), sponsored by Zhejiang Hisun Pharmaceutical Co., Ltd.. Started Oct 2014; status: active.

02

Drugs

biphasic human insulin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on CTR20140675.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140675.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call